 Stage 2-Prospective Monitoring Study: Blood will be collected from patients at diagnosis andor at routine clinical follow-up. Patients can be up to five years from diagnosis n65 3 samples. One source of blood will be collected. Patients will be followed for 3 years. The final design of the Stage 2 study will be after the completion of Stage 1 study. 